Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review.
about
IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumorsDoxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking.Hypoxia as a target for drug combination therapy of liver cancer.Identification of binding mechanisms in single molecule-DNA complexesThe liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers.A chemical perspective on the anthracycline antitumor antibioticsA high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancerAnthracyclines selectively decrease alpha cardiac actin mRNA abundance in the rat heartCheckpoint Kinase 1 Activation Enhances Intestinal Epithelial Barrier Function via Regulation of Claudin-5 Expression.A small molecule screening to detect potential therapeutic targets in human podocytes.Competitive Growth Enhances Conditional Growth Mutant Sensitivity to Antibiotics and Exposes a Two-Component System as an Emerging Antibacterial Target in Burkholderia cenocepaciaTopoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion.Therapeutic applications of PARP inhibitors: anticancer therapy and beyondClinical monitoring in a patient with Friedreich ataxia and osteogenic sarcoma.Sensitivity of RECQL4-deficient fibroblasts from Rothmund-Thomson syndrome patients to genotoxic agents.Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells.Radiation-induced gene signature predicts pathologic complete response to neoadjuvant chemotherapy in breast cancer patientsHuman DNA ligases: a comprehensive new look for cancer therapy.Activating secondary metabolism with stress and chemicals.Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity.A 19F-NMR study of 2-fluoro-4-demethoxydaunomycin intercalation complexes with the decanucleotides d(G-C)5 and d(A-T)5.Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells.Optically modulated cancer therapeutic delivery: past, present and future.Mitoxantrone, More than Just Another Topoisomerase II Poison.Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism.A novel hanging spherical drop system for the generation of cellular spheroids and high throughput combinatorial drug screening.Induction of cell death by a novel naphthoquinone containing a modified anthracycline ring system.Adriamycin and altered membrane functions in rat heartsDual-Cross-Linked Methacrylated Alginate Sub-Microspheres for Intracellular Chemotherapeutic Delivery.Acute circulatory effects of doxorubicin in the conscious dog.Response of rat incisor mesenchymal cells to doxorubicin after bleomycin pretreatment.Correlation between anthracycline structure and human DNA ligase inhibition.Broad spectrum thiopeptide recognition specificity of the Streptomyces lividans TipAL protein and its role in regulating gene expression.On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.Development of multi-layered and multi-sensitive polymeric nanocontainers for cancer therapy: in vitro evaluationSuperparamagnetic iron-doped nanocrystalline apatite as a delivery system for doxorubicinComparative Study of Reversed-Phase High-Performance Liquid Chromatography and Ultraviolet–Visible Spectrophotometry to Determine Doxorubicin in pH-Sensitive Nanoparticles
P2860
Q28288521-9DC0F197-D4DC-461B-99FA-7F6EB0B4F0B7Q30472420-E5E8C711-E0DC-4B76-A105-A3EF48C7046EQ30491780-B6BB70FB-E357-484E-B7D0-C7D26C11DB42Q34182773-4ACFA884-1918-4F63-9777-ABCF4BCCD16FQ34201358-0976FF2F-B6C1-48E1-902A-57E66023410EQ35035606-187F4BE8-E06A-489E-A848-D5E45CA25F0FQ35677211-F30834C5-91CB-4272-81D0-884781CF77E3Q35832113-28AA8915-ABD2-4490-B46D-990DD8FEC2C2Q35883943-C22F5D51-178F-4362-ABD0-F69165FE59BEQ36168378-CC7B163E-A67D-4FED-9DA4-D888404899D1Q36178767-66CC8842-EC8E-42C5-B27F-B32F8FBA8487Q36335123-17E47C4C-987D-4882-9249-09DABE6C77BAQ36853236-BE59325B-6A26-4C5D-B0ED-8D0AC90FC1BCQ36908243-D212D5B2-2A3C-4CFE-B571-13EA1B5C97D6Q36978188-015BE331-F3B8-4A7B-8D65-CA07D102840EQ37112491-EF3B25A6-8316-420E-8A30-41D50DE05841Q37244377-D69FD67A-3817-4B1C-B1C7-10014206747DQ38130159-D175E62E-41CD-4EAF-8F4F-54B87E240ED1Q38170294-FBDB79F7-0623-4A06-AE67-F18E6E739D5BQ38233071-5E2EF2A6-FB9C-4C5E-BA59-917CD4FF1BD7Q38345490-1CD12D0B-F5EC-4A06-B10D-F640B105B9CCQ38371589-C9AEBEFE-3E0B-4DD3-A22D-5BF3EA08F1BCQ38498017-7ED0551C-2082-43BA-A9F1-5F7DF8AF4440Q38569206-1BE9C858-4DCE-4B78-91CF-4B62337F62EDQ38779463-040499D5-C7DD-4215-87D1-A1C78C685162Q38848195-C7296630-E189-447F-B47A-D4397CDF3EA8Q39491036-9F6BA5BB-FF68-4971-B8E4-528F3095C007Q41556050-BDE28654-5C63-4977-9494-459FA282519EQ42060427-473E3EC2-2E21-4CBE-9AE0-80E2D461B1E4Q42209459-D8BCA484-5677-4A00-BE9A-1C8160858E39Q42486545-900300D3-A3C8-46D6-AA73-481DF58E75B4Q42862805-03B9F33F-C4E9-479D-BDB4-4427FE9EAA46Q52535716-69FF4921-6FFA-45BC-9009-89C4227A4C4AQ55054276-1445C785-2042-45CD-9B95-87D3BBDF3460Q57050473-78123710-B2A0-4FAB-A95A-5417577CE7BDQ57879972-E8DF2707-88BD-4B27-AA70-6EB33D01B817Q58292689-59F090E4-AF3B-49D4-99E9-DBCBA46E5D1C
P2860
Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Daunorubicin and doxorubicin, ...... hemical and biological review.
@en
type
label
Daunorubicin and doxorubicin, ...... hemical and biological review.
@en
prefLabel
Daunorubicin and doxorubicin, ...... hemical and biological review.
@en
P1433
P1476
Daunorubicin and doxorubicin, ...... hemical and biological review.
@en
P2093
Aubel-Sadron G
Londos-Gagliardi D
P304
P356
10.1016/0300-9084(84)90018-X
P577
1984-05-01T00:00:00Z